Hypertriglyceridemia Medication Study

Now Enrolling in Boise, Cincinnati (Blue Ash), Cleveland, Lincoln, New Smyrna Beach, North Hollywood, Salt Lake City, San Diego, Syracuse, Union, and Valparaiso

Now Enrolling

About this research study

Hypertriglyceridemia refers to an elevated level of triglycerides (lipids) in the bloodstream. A severe elevation of triglycerides can increase a person's risk for pancreatitis.

Velocity is conducting a clinical research study for an investigational medication for hypertriglyceridemia.

Eligible participants...

  • Must be age 18 to 79 years
  • Must be on statin or non-statin lipid altering therapy such as ezetimibe, niacin, fibrates, prescription omega-3 products, or other herbal products or dietary supplements with potential lipid altering effects.
  • Must NOT be using weight loss drugs known to affect intestinal fat absorption including over-the-counter products
  • Will receive compensation for study-related time
  • Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.

Enter your info

Name(Required)
Date of birth(Required)
Age can help us determine study eligibility (you must be age 18 or older to submit this form).
Race(Required)
Select one or more designations that best describe you. This information can help Velocity better ensure all populations are represented in research.
This field is hidden when viewing the form

By entering your email address and/or phone number on this form, you represent that you are at least 18 years of age and consent to receiving communications (e.g., call, SMS, text, and/or email) from Velocity and/or the research site(s) involved with the clinical trials that appear on this website. Messaging frequency varies. Message and data rates may apply. You may reply with STOP to a text message. For any help regarding messaging, please email us at info@velocityclinical.com. For full details, refer to Velocity's privacy policy and website terms of use. Submissions on this website are not monitored 24/7. Do NOT submit personal health or medical information on this form. If you are enrolled in a trial and have questions, please call your research site.

This field is for validation purposes and should be left unchanged.

Study Locations

Boise (Meridian), Idaho • Velocity Clinical Research

2950 E. Magic View Dr., Suite 100, Meridian, ID 83642
Phone: (208) 377-8653

Cincinnati (Blue Ash), Ohio • Velocity Clinical Research

4260 Glendale Milford Road, Suite 201, Cincinnati, OH 45242
Phone: (513) 769-2767

Cleveland, Ohio • Velocity Clinical Research

3619 Park East Dr., Suite 300, Beachwood, OH 44122
Phone: (216) 682-0320

Lincoln, Nebraska • Velocity Clinical Research at Pioneer Heart Institute

6940 Van Dorn Street, Suite 201, Lincoln, NE 68506
Phone: (531) 530-2801

New Smyrna Beach (Edgewater), Florida • Velocity Clinical Research

1410 S. Ridgewood Avenue, Edgewater, FL 32132
Phone: (386) 428-7730

North Hollywood, California • Velocity Clinical Research

6400 Laurel Canyon Blvd., Suite 300A, North Hollywood, CA 91606
Phone: (818) 487-3741

Salt Lake City (West Jordan), Utah • Velocity Clinical Research

3590 West 9000 South, Suite 300, West Jordan, UT 84088
Phone: (801) 542-8190

San Diego (La Mesa), California • Velocity Clinical Research

5565 Grossmont Center Dr Building 2, Suite 1, La Mesa, CA 91942
Phone: (619) 567-1550

Syracuse, New York • Velocity Clinical Research

5000 Brittonfield Parkway, Suite B105, East Syracuse, NY 13057
Phone: (315) 760-5905

Union, South Carolina • Velocity Clinical Research

1005 Thompson Blvd, Union, SC 29379
Phone: (864) 427-1172

Valparaiso, Indiana • Velocity Clinical Research

55 University Drive, Suite 106, Valparaiso, IN 46383
Phone: (219) 464-8302

©2023 Velocity Clinical Research | All Rights Reserved | Privacy Policy